Ransomware victim disclosure
← All victims吉林省药品监督管理局 (Jilin Provincial Drug Regulatory Administration)
listed as AG真人 · Claimed by Pryx · listed 6 days ago
Status timeline
- Listed
May 15, 2026
Current state: Listed for ransom
At a glance
About the victim
AI dossier — public-source company profileThe Jilin Provincial Drug Regulatory Administration (吉林省药品监督管理局) is the provincial-level government authority in Jilin Province, China, responsible for regulating pharmaceuticals, medical devices, and cosmetics. It oversees drug production and distribution licensing, medical device registration and approval, cosmetics quality supervision, and enforcement of drug laws across Jilin Province. The agency publishes regulatory notices, quality announcements, and administrative approval results for industry and the public.
- Industry
- Government Drug & Medical Device Regulation
- Address
- 吉林省长春市经济技术开发区湛江路657号（仙台大街与湛江路交会处）, Changchun, Jilin Province, China
Attack summary
Severity: high — The victim is a provincial government regulatory authority handling regulated pharmaceutical, medical device, and licensing data including personally identifiable information of licensed professionals and detailed industry compliance records. Compromise of a government healthcare regulator constitutes a high-severity incident involving sensitive regulatory and administrative data, even absent explicit confirmation of large-scale exfiltration.The Pryx group has listed the Jilin Provincial Drug Regulatory Administration as a victim, claiming access to its web presence and internal content; the post does not explicitly state encryption or quantified exfiltration, but references to internal regulatory documents and administrative systems suggest potential data exposure.
Data the group says was taken
AI dossier — extracted from the leak post- Medical device registration approval records
- Drug production licence issuance and revocation notices
- Drug distribution licence records
- Cosmetics production licence records
- Pharmaceutical quality inspection reports
- Registered pharmacist credential records
- Administrative approval results
- Internal regulatory notification documents
- Government procurement records
- Annual budget and financial reports
What the group claims
Chinese medical device regulatory authority publishing notices about Class II medical device registration approval processes and announcements.
The leak post
captured from the group's site* [AG真人关于印发《第二类医疗器械注册审批流程》的通知 吉药监械注册〔2026...](https://www.pryx.cc/zxfw_84842/tzwj/202603/t20260325_9456045.html "AG真人关于印发《第二类医疗器械注册审批流程》的通知 吉药监械注册〔2026〕10 号") * [AG真人 关于批准注册医疗器械产品的公告 （2026年第4期）](https://www.pryx.cc/zxfw_84842/gsgg/pgzg/202605/t20260508_9587321.html "AG真人 关于批准注册医疗器械产品的公告 （2026年第4期）")
Screenshot of the leak post
Sources
- Victim sitehttps://www.pryx.cc/zxfw_84842/
- Leak posthttp://pryx.cc
Source
Indexed 6 days agoThis page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.